N/A

N/A

N/A

N/A

Cristina Chimenti is currently working as an associate professor at Sapienza University of Rome, Rome, Italy. Her top areas of expertise are myocarditis, cardiomyopathy, Fabry Disease, patent Foramen Ovale repair, and cardiac ablation. Her clinical research consists of co-authoring 113 peer-reviewed articles in the past 15 years.

N/A

Roberta Rossini is currently working as a cardiologist at Azienda Ospedaliera S.Croce e Carle Cuneo, Cuneo, Italy. Her research interests include cardiac catheterization, coronary angiography, atherosclerosis, heart failure, interventional cardiology, myocardial Infarction, PCI, clinical cardiology, acute myocardial infarction, and echocardiography. Her scientific output includes 133 publications, corresponding to 2304 citations (h-index 26) (Scopus, 23 November 2023).

N/A

Stefano Cornara is an EP interventional cardiologist at the Cardiac Intensive Care Division of Cardiology, San Paolo Hospital, Savona, Italy. Stefano Cornara earned an M.D. from the Università degli Studi di Pavia in 2013. Stefano Cornara was a medical resident at the IRCCS Istituto Nazionale dei Tumori Foundation, a resident physician in anesthesia resuscitation and intensive care at the University of Milan (2014–2015), and a resident physician in cardiology at the Fondazione I.R.C.C.S. Policlinico San Matteo Pavia (2015–2019).

N/A

N/A

Concetta Di Nora is currently working as a cardiologist in the Cardiothoracic Department and Transplant Heart Team Member of Udine Hospital. She is interested in advanced heart failure management, heart transplantation, assisted ventricular device therapy, and echocardiography. Her scientific output includes 49 publications, corresponding to 700 citations (h-index 12) (Scopus, 23 November 2023).

N/A

Sandro Gelsomino studied medicine in Bologna. He was trained as a heart surgeon at the University Hospital S. Orsola Malpighi in Bologna and qualified in 1995. He was a fellow at the Bologna University from 1990 to 1995. He was a resident cardiac surgeon at Pinna Pintor Clinic and a staff member at Brescia Hospital from 1995 to 1997. From 1998 to 2003 he was a cardiac surgeon staff member at S. Maria della Misericordia Hospital, Udine, Italy, and a member of the stentless valve program. From 2003 to 2007 he was a staff surgeon at Careggi Hospital Florence, Italy and he carried out a program on ischemic mitral regurgitation. From 2008 to 2006 he was the director (head) of the Experimental Surgery Unit, Careggi Hospital Florence. In 2009, he obtained his Ph.D. on this subject at the Faculty of Medicine and Life Sciences at Maastricht University. In 2014, he was appointed as an associate professor and in 2018 he became professor of heart surgery. One of the main topics of his research is atrial fibrillation (AF). He is developing a new true hybrid true bipolar tool (CORDIA) for the ablation of atrial fibrillation which has been patented with the support of Maastricht University. In addition, he is developing, in collaboration with MERLIN, a patch for several applications in the field of cardiovascular medicine, apart from AF. With the University of Florence, he is involved in the program for new anti-oxidants for the treatment of AF.

Roberto Ceravolo is currently working as an associate professor at the Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. His research interests include neurosciences and neurology, cardiovascular systems, and cardiology. His scientific output includes 292 publications, corresponding to 8960 citations (h-index 48) (Scopus, 23 November 2023).

N/A

N/A

Furio Colivicchi is a clinical cardiologist with a strong interest in acute cardiac care, clinical cardiovascular pharmacology, and secondary cardiovascular prevention. He is the director of the Cardiology Division at S. Filippo Neri Hospital in Rome, Italy, and a contract professor of cardiovascular medicine at the School of Physiotherapy at Tor Vergata's University School of Medicine in Rome, Italy. He currently is President-Elect of the Italian National Association of Hospital Cardiologists (ANMCO).

N/A

Michele Massimo Gulizi is currently working as the chief of the Cardiology Department at Garibaldi-Nesima Hospital, Catania, Italy. His research interests include acute coronary syndrome; atrial fibrillation; anticoagulant agents; warfarin; Idarucizumab; Dabigatran Etexilate; edoxaban; Proprotein Convertase 9; alirocumab; and familial hypercholesterolemia. His scientific output includes 336 publications, corresponding to 13633 citations (h-index 35) (Scopus, 23 November 2023).

N/A